KORU Medical Systems, Inc. (KRMD)
(Delayed Data from NSDQ)
$3.26 USD
-0.02 (-0.61%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $3.27 +0.01 (0.31%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
KRMD 3.26 -0.02(-0.61%)
Will KRMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KRMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KRMD
KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2
American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates
KRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
Integer (ITGR) Soars 3.8%: Is Further Upside Left in the Stock?
Other News for KRMD
Q2 2025 KORU Medical Systems Inc Earnings Call Transcript
KORU Medical raises FY25 revenue view to $39.5M-$40.5M from $38.5M-$39.5M
KORU Medical reports Q2 adjusted EPS 1c, consensus (2c)
KORU Medical Systems Inc Reports Q2 2025 Earnings: EPS at $0. ...
Earnings Scheduled For August 6, 2025